Key Dates

  • AGM Date: Wednesday, September 16, 2026
  • AGM Time: 11:00 AM IST
  • AGM Mode: Video Conferencing/Other Audio Visual Means (VC/OAVM)
  • Notice Dispatch Date: August 24, 2026 (electronically to registered email IDs)
  • Record Date for AGM: Wednesday, September 9, 2026 (for determining members entitled to vote)
  • Register of Members Closure: Thursday, September 10, 2026 to Wednesday, September 16, 2026 (both days inclusive)
  • Remote e-Voting Period: September 13, 2026 (9:00 AM IST) to September 15, 2026 (5:00 PM IST)
  • Deadline for Member Queries: Monday, September 14, 2026 (via email to cs@kronoxlabsciences.com)

Business to be Transacted

Ordinary Business

1. Item 1: To receive, consider, and adopt the Audited Standalone Financial Statements for the financial year ended March 31, 2026, along with the Reports of the Board of Directors and Auditors.

2. Item 2: To declare a final dividend of ₹0.50 per equity share for the financial year 2025-26.

3. Item 3: To appoint a director in place of Mr. Jogindersingh Jaswal (DIN: 02385809), who retires by rotation and offers himself for re-appointment.

Special Business

4. Item 4: To ratify the remuneration payable to the Cost Auditors for FY 2026-27.

  • Resolution: Ordinary Resolution
  • Auditor Firm: M/s. Diwanji & Associates, Cost Accountants (Firm Registration No. 000318)
  • Remuneration: ₹90,000 per annum plus applicable taxes.
  • Appointment Authority: Board of Directors, based on the recommendation of the Audit Committee.
  • Rationale: Ratification is required pursuant to Section 148 of the Companies Act, 2013 and the Companies (Audit and Auditors) Rules, 2014.

Director Re-appointment Details (Mr. Jogindersingh Jaswal)

  • Date of First Appointment: November 18, 2008
  • Date of Appointment in Current Tenure: September 1, 2025
  • Experience: 37 Years
  • Qualification: B.Sc.
  • Expertise: Production, Quality Control & Assurance, and Human Resource activities.
  • Past Experience: Worked with Ranbaxy Laboratories Limited and Ranbaxy Fine Chemicals Limited (1994-2001).
  • Shareholding: 26.39% of the company.
  • Board Meeting Attendance: 6 out of 7 meetings in the last year.
  • Terms: Re-appointment as a retiring director.

Dividend and Tax Information

  • A final dividend of ₹0.50 per equity share is proposed for FY25-26.
  • The company will deduct Tax at Source (TDS) on dividend payments as per the Income Tax Act, 1961 (amended by Finance Act, 2020).
  • Members will receive a separate email with details on submitting documents/declarations for beneficial tax treatment.
  • Members holding shares in electronic form must ensure their bank account details are updated with their Depository Participants (DPs) for dividend receipt.

Voting Information

  • Scrutinizer: Mr. Devesh A Pathak, Proprietor of M/s. Devesh Pathak & Associates, Company Secretaries, Vadodara.
  • E-Voting Service Provider: KFin Technologies Limited (KFin).
  • Remote e-Voting Event Number (EVEN): 10093
  • Grievance Officer: Mr. Nikhil Goswami, Company Secretary & Compliance Officer (Contact: +91-2662-299002, cs@kronoxlabsciences.com).
  • Members can vote remotely or register to speak at the AGM via KFin's platform (https://emeetings.kfintech.com).

Document Availability

  • The Notice of AGM and Annual Report for 2025-26 are available on the company's website (www.kronoxlabsciences.com) and the websites of BSE (www.bseindia.com) and NSE (www.nseindia.com).
  • Physical inspection of documents referred to in the notice is available at the Registered Office on working days (10:00 AM to 1:00 PM) until the conclusion of the meeting.